CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The EuroVision project focuses on developing a gene therapy for Usher syndrome type 1B, caused by mutations in the MYO7A gene, which leads to vision loss, hearing impairment, and balance issues. The project aims to advance pre-clinical development and prepare for a first-in-human clinical trial using a novel lentiviral…
Sight is the most treasured of our senses, followed by hearing and balance.
Moderate to severe vision loss affects more than 216 million people worldwide, with an estimated 36 million people suffering from blindness.
Monogenic diseases caused by mutations in genes such as MYO7A are responsible for vision loss in over two million people.
As current treatment options for genetic vision loss are limited or non-existent, there is a high clinical need for innovative approaches, such as gene therapy.…
MEDIZINISCHE HOCHSCHULE HANNOVER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
